Jaume Capdevila, M.D.; Ph.D.
Hospital Universitario Vall d´Hebron
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jaume Capdevila, M.D.; Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:45 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07061080 · Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamabGrupo Espanol de Tumores Neuroendocrinos · terminated · Advanced Neuroendocrine Carcinomas of The Digestive System, Advanced Neuroendocrine Carcinomas Unknown Primary Origin
- Ph2NCT06235216 · Sacituzumab govitEcan in THYroid CancersGrupo Espanol de Tumores Neuroendocrinos · recruiting · Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer · study chair
- Ph3NCT05918302 · Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.Grupo Espanol de Tumores Neuroendocrinos · recruiting · Neuroendocrine Tumors, Lung Neuroendocrine Neoplasm, Thymus Neoplasms
- Ph2NCT04400474 · Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN StudyGrupo Espanol de Tumores Neuroendocrinos · completed · Neuroendocrine Tumor, Anaplastic Thyroid Cancer, Adenocarcinoma
- Ph2NCT03753919 · Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY TrialGrupo Espanol de Tumores Neuroendocrinos · terminated · Metastatic Thyroid Papillary Carcinoma, Metastatic Thyroid Follicular Carcinoma, Metastatic Thyroid Cancer
- Ph2NCT03095274 · Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung OriginGrupo Espanol de Tumores Neuroendocrinos · completed · Neuroendocrine Tumors, Neuroendocrine Neoplasm of Lung
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.